Astec LifeSciences Limited · NSE: ASTEC · BSE: 533138
Astec LifeSciences
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 31 Jul 2026.
Q1 FY27 · Consolidated
Revenue
83.56₹ Cr
−8.3% vs year ago
Net profit
(18.71)₹ Cr
Loss narrowed vs year ago
EPS, basic
(8.40)₹
not comparable vs year ago
Net margin
-22.4%
+13.9 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 83.56 | −8.3% | (18.71) | Loss narrowed | (8.40) | 31 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 158.62 | +32.7% | (7.75) | Loss narrowed | (3.48) | 27 Apr 2026 |
| Q3 FY26Oct–Dec 2025 | 124.72 | +32.9% | (15.69) | Loss narrowed | (7.04) | 30 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 73.72 | −25.2% | (24.42) | Loss narrowed | (11.35) | 29 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 91.08 | +31.3% | (33.03) | Loss narrowed | (16.85) | 28 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 119.53 | −22.3% | (16.08) | Loss widened | (8.20) | 09 May 2025 |
| Q3 FY25Oct–Dec 2024 | 93.86 | +84.8% | (40.37) | Loss widened | (20.59) | 12 Mar 2025 |
| Q2 FY25Jul–Sep 2024 | 98.55 | −11.1% | (38.55) | Loss widened | (19.66) | 08 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 69.37 | −51.4% | (39.72) | Loss widened | (20.26) | 20 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 153.75 | +21.1% | (0.96) | Loss narrowed | 0.50 | 08 May 2024 |
| Q3 FY24Oct–Dec 2023 | 50.79 | −56.7% | (24.33) | Turned loss | (12.41) | 05 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 110.79 | −44.5% | (13.42) | Turned loss | (6.85) | 30 Oct 2023 |
| Q1 FY24Apr–Jun 2023 | 142.85 | −22.5% | (8.19) | Turned loss | (4.18) | 28 Jul 2023 |
| Q4 FY23Jan–Mar 2023 | 126.97 | −53.3% | (4.97) | Turned loss | (2.54) | 04 May 2023 |
| Q3 FY23Oct–Dec 2022 | 117.18 | −32.4% | 0.85 | −96.6% | 0.43 | 31 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 199.75 | +94.7% | 18.31 | +101.8% | 9.34 | 29 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 184.27 | +43.2% | 11.41 | −12.2% | 5.82 | 26 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 271.98 | +58.2% | 43.06 | +79.7% | 21.97 | 04 May 2022 |
| Q3 FY22Oct–Dec 2021 | 173.35 | +49.4% | 24.75 | +250.4% | 12.63 | 27 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 102.57 | −33.8% | 9.08 | −49.2% | 4.63 | 28 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 128.66 | +14.9% | 12.99 | −19.7% | 6.63 | 29 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 171.92 | −4.8% | 23.97 | −23.1% | 12.24 | 03 May 2021 |
| Q3 FY21Oct–Dec 2020 | 116.01 | −7.1% | 7.06 | −41.9% | 3.61 | 27 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 155.00 | +10.5% | 17.85 | +237.7% | 9.12 | 03 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 111.94 | +45.4% | 16.19 | Turned profit | 8.27 | 23 Jul 2020 |
| Q4 FY20Jan–Mar 2020 | 180.57 | +35.0% | 31.18 | +145.0% | 15.94 | 06 May 2020 |
| Q3 FY20Oct–Dec 2019 | 124.83 | +4.5% | 12.17 | +21.9% | 6.22 | 31 Jan 2020 |
| Q2 FY20Jul–Sep 2019 | 140.21 | +24.4% | 5.29 | −54.3% | 2.70 | 30 Oct 2019 |
| Q1 FY20Apr–Jun 2019 | 76.99 | +17.6% | (1.11) | Turned loss | (0.57) | 27 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 133.76 | — | 12.73 | — | 6.50 | 02 May 2019 |
| Q3 FY19Oct–Dec 2018 | 119.43 | — | 9.98 | — | 5.10 | 27 Jan 2019 |
| Q2 FY19Jul–Sep 2018 | 112.72 | — | 11.57 | — | 5.92 | 30 Oct 2018 |
| Q1 FY19Apr–Jun 2018 | 65.47 | — | 1.49 | — | 0.08 | 02 Aug 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 83.56 | −8.3% | (18.74) | Loss narrowed | (8.41) | 31 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 158.62 | +32.7% | (7.78) | Loss narrowed | (3.49) | 27 Apr 2026 |
| Q3 FY26Oct–Dec 2025 | 124.72 | +32.9% | (15.72) | Loss narrowed | 7.06 | 30 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 73.72 | −25.2% | (24.45) | Loss narrowed | (11.39) | 29 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 91.08 | +31.3% | (33.06) | Loss narrowed | (16.86) | 28 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 119.53 | −22.3% | (16.10) | Loss widened | (8.21) | 09 May 2025 |
| Q3 FY25Oct–Dec 2024 | 93.86 | +84.8% | (40.40) | Loss widened | (20.60) | 12 Mar 2025 |
| Q2 FY25Jul–Sep 2024 | 98.55 | −11.1% | (38.57) | Loss widened | (19.67) | 08 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 69.37 | −51.4% | (39.74) | Loss widened | (20.26) | 20 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 153.75 | +21.1% | (0.99) | Loss narrowed | 0.50 | 08 May 2024 |
| Q3 FY24Oct–Dec 2023 | 50.79 | −56.7% | (24.35) | Turned loss | (12.42) | 05 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 110.79 | −44.5% | (13.45) | Turned loss | (6.86) | 30 Oct 2023 |
| Q1 FY24Apr–Jun 2023 | 142.85 | −22.5% | (8.21) | Turned loss | (4.19) | 28 Jul 2023 |
| Q4 FY23Jan–Mar 2023 | 126.97 | −53.3% | (5.00) | Turned loss | (2.55) | 04 May 2023 |
| Q3 FY23Oct–Dec 2022 | 117.18 | −32.4% | 0.83 | −96.7% | 0.42 | 31 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 199.75 | +94.7% | 18.30 | +101.9% | 9.34 | 29 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 184.27 | +43.2% | 11.39 | −12.2% | 5.81 | 26 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 271.98 | +58.2% | 43.04 | +79.8% | 21.97 | 04 May 2022 |
| Q3 FY22Oct–Dec 2021 | 173.35 | +49.4% | 24.74 | +251.0% | 12.63 | 27 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 102.57 | −33.8% | 9.06 | −48.3% | 4.63 | 28 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 128.66 | +14.9% | 12.97 | −19.8% | 6.62 | 29 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 171.92 | −4.6% | 23.94 | −23.2% | 12.23 | 03 May 2021 |
| Q3 FY21Oct–Dec 2020 | 116.01 | −7.1% | 7.05 | −42.0% | 3.60 | 27 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 155.00 | +10.5% | 17.53 | +232.5% | 8.96 | 03 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 111.94 | +45.4% | 16.17 | Turned profit | 8.26 | 23 Jul 2020 |
| Q4 FY20Jan–Mar 2020 | 180.18 | +34.7% | 31.17 | +145.4% | 15.94 | 06 May 2020 |
| Q3 FY20Oct–Dec 2019 | 124.83 | +4.5% | 12.15 | +22.3% | 6.21 | 31 Jan 2020 |
| Q2 FY20Jul–Sep 2019 | 140.21 | +24.4% | 5.27 | −54.4% | 2.70 | 30 Oct 2019 |
| Q1 FY20Apr–Jun 2019 | 76.99 | +17.6% | (1.12) | Turned loss | (0.57) | 27 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 133.76 | — | 12.70 | — | 6.50 | 02 May 2019 |
| Q3 FY19Oct–Dec 2018 | 119.43 | — | 9.94 | — | 5.09 | 27 Jan 2019 |
| Q2 FY19Jul–Sep 2018 | 112.72 | — | 11.57 | — | 5.92 | 30 Oct 2018 |
| Q1 FY19Apr–Jun 2018 | 65.47 | — | 1.48 | — | 0.08 | 02 Aug 2018 |
66 filings on record for this company.